The Week In Cannabis: Tilray Earnings, NY Hits $1B In Sales, DoorDash Embraces Hemp, Ukraine And More
New York hits $1B cannabis sales, Ukraine registers first medical product. Updates on DoorDash, Tilray, Agrify and more.
Cannabis companies say DEA has closed mind against a less-dangerous pot ranking
Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under the Controlled Substances Act.
JD Supra7m
The Week in Weed: January 2025 # 2
Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. New York released updated ...
Cannabis and Trump 2.0: 2025 and beyond
Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss what the cannabis sector can expect as 2025 ...
Cannabis/Beer Company Tilray Outlines Plan To Reduce Its Beverage Portfolio, Reports Mixed Q2 Earnings
Tilray Brands reported 9% YoY revenue growth in Q2 2025 to $210.95 million. Fiscal 2025 guidance remains strong at $950 ...
MJBizDaily2d
Colorado shut out of marijuana rescheduling hearings by ‘biased’ DEA, filing alleges
The DEA rejected a September request from Colorado officials to participate in the United States' historic marijuana ...
cannabiswire1d
Motion Filed to Remove “Biased” DEA Ahead of Cannabis Rescheduling Hearings
A group of pro-cannabis entities scheduled to present in the forthcoming cannabis rescheduling hearing have filed a new ...
Marijuana Moment2d
DEA Judge Orders Agency To Respond To New Allegations It Opposes Marijuana Rescheduling And Improperly Conspired With Prohibitionists
A Drug Enforcement Administration (DEA) judge has ordered the agency to respond to new allegations that it opposes the Biden ...